Page last updated: 2024-11-08

ponceau s

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Ponceau S : An organic sodium salt that is the tetrasodium salt of 3-hydroxy-4-({2-sulfo-4-[(4-sulfophenyl)diazenyl]phenyl}diazenyl)naphthalene-2,7-disulfonic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2723873
CHEBI ID90319
MeSH IDM0101966

Synonyms (40)

Synonym
c.i. acid red 112, tetrasodium salt
6226-79-5
c.i. 27195
ponceau s extra
ponceau red s
c.i. acid red 112
nsc-16216
ponceau s
2,7-naphthalenedisulfonic acid, 3-hydroxy-4-((2-sulfo-4-((4-sulfophenyl)azo)phenyl)azo)-, tetrasodium salt
2-hydroxy-1-((4((4-sulfophenyl)azo)-2-sulfophenyl)azo)naphthalene-3,6-disulfonic acid, tetrasodium salt
tetrasodium 3-hydroxy-4-(2-sulphonato-4-(4-sulphonatophenylazo)phenylazo)naphthalene-2,7-disulphonate
einecs 228-319-2
nsc 16216
acid red 112
unii-t1c2ugs05f
t1c2ugs05f ,
2,7-naphthalenedisulfonic acid, 3-hydroxy-4-(2-(2-sulfo-4-(2-(4-sulfophenyl)diazenyl)phenyl)diazenyl)-, sodium salt (1:4)
AKOS015902723
2,7-naphthalenedisulfonic acid, 3-hydroxy-4-[[2-sulfo-4-[(4-sulfophenyl)azo]phenyl]azo]-, tetrasodium salt
AKOS024375433
3-hydroxy-4-[2-[2-sulfo-4-[2-(4-sulfophenyl)diazenyl]phenyl]diazenyl]-2,7-naphthalenedisulfonic acid tetrasodium salt
CHEBI:90319
tetrasodium 3-hydroxy-4-({2-sulfonato-4-[(4-sulfonatophenyl)diazenyl]phenyl}diazenyl)naphthalene-2,7-disulfonate
AKOS024458537
ponceau s, electrophoresis grade
mfcd00003892
ponceau-s
AMY22410
tetrasodium;3-hydroxy-4-[[2-sulfonato-4-[(4-sulfonatophenyl)diazenyl]phenyl]diazenyl]naphthalene-2,7-disulfonate
p 7170
2,7-naphthalenedisulfonic acid, 3-hydroxy-4-[[2-sulfo-4-[(4-sulfophenyl)azo]phenyl]azo]-, tetrasodium salt (9ci); c.i. acid red 112, tetrasodium salt (8ci); ponceau s (6ci); c.i. acid red 112; ponceau red s; ponceau s extra
3-hydroxy-4-((2-sulfo-4-((4-sulfophenyl)diazenyl)phenyl)diazenyl)naphthalene-2,7-disulfonic acid, tetrasodium salt
DTXSID60889378
2,7-naphthalenedisulfonic acid,3-hydroxy-4-[[2-sulfo-4-[(4-sulfophenyl)azo]phenyl]azo]-, tetrasodiumsalt
HB0819
c22h12n4na4o13s4
ponceau s sodium salt
AS-83593
ponceau-s, sodium salt
6226-79-5 (solid)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The potentially toxic effect of PS on the transport function of HSA in a normal physiological environment was analyzed."( Potential protein toxicity of synthetic pigments: binding of poncean S to human serum albumin.
Chen, L; Gao, HW; Wang, SL; Wang, Y; Wu, LL; Xu, Q; Yuan, Y, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" Batch studies were performed by varying pH, biosorbent dosage and initial dye concentrations."( Equilibrium, kinetic and thermodynamic studies on the biosorption of reactive acid dye on Enteromorpha flexuosa and Gracilaria corticata.
Nethaji, S; Nisha, LL; Sivasamy, A, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
histological dyeA dye used in microscopic or electron microscopic examination of cells and tissues to give contrast and to highlight particular features of interest, such as nuclei and cytoplasm.
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organic sodium salt
organosulfonate saltAny organic salt prepared using an organosulfonic acid as the acid component.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (60)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (5.00)18.7374
1990's14 (23.33)18.2507
2000's19 (31.67)29.6817
2010's20 (33.33)24.3611
2020's4 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (1.64%)4.05%
Observational0 (0.00%)0.25%
Other60 (98.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]